Previous Article | Next Article 
Journal of Virology, October 2000, p. 9441-9450, Vol. 74, No. 20
0022-538X/00/$04.00+0
Adeno-Associated Virus Type 2 Rep78 Induces
Apoptosis through Caspase Activation Independently of p53
Michael
Schmidt,
Sandra
Afione, and
Robert M.
Kotin*
Laboratory of Biochemical Genetics, National
Heart, Lung, and Blood Institute, National Institutes of Health,
Bethesda, Maryland 20892
Received 16 May 2000/Accepted 25 July 2000
 |
ABSTRACT |
Adeno-associated virus (AAV) type 2 Rep78 is a multifunctional
protein required for AAV DNA replication, integration, and gene
regulation. The biochemical activities of Rep78 have been described,
but the effects of Rep proteins on the cell have not been
characterized. We have analyzed Rep-mediated cytotoxicity. We
demonstrated that Rep78 expression is sufficient to induce cell death
and disruption of the cell cycle. Cell death was found to be mediated
by apoptosis. Rep78 expression resulted in the activation of caspase-3,
a terminal caspase directly involved in the execution of cell death. A
peptidic inhibitor of caspase-3, Z-Asp-Glu-Val-Asp-fluoromethylketone
(Z-DEVD-FMK), abrogated Rep78-induced apoptosis, indicating that
Rep78-mediated apoptosis is caspase-3 dependent. Rep78 induced
apoptosis in wild-type p53-containing human embryonal carcinoma NT-2
cells and in p53-null promyelocytic human HL-60 cells, indicating that
at least one pathway of Rep78-induced apoptosis is p53 independent.
Apoptosis was shown to occur during the G1 and early S
phases of the cell cycle. By analyzing the effects of Rep78 mutations
on cell viability, the cause of cell death was attributed in part to
two biochemical activities of Rep78, DNA binding and ATPase/helicase
activity. The endonuclease activity of Rep78 did not contribute to
apoptosis induction.
 |
INTRODUCTION |
Adeno-associated virus type
2 (AAV-2) is classified as a member of the family
Parvoviridae and has been assigned to the genus Dependovirus because efficient replication typically
requires a coinfecting helper virus (5, 54). Under
nonpermissive conditions, AAV-2 establishes a latent infection by
locus-specific integration into the q arm of chromosome 19 of the
infected cell (32, 33, 51). AAV-2 is a small, nonenveloped,
icosahedral virus with a linear, single-stranded DNA genome of 4,680 nucleotides (nt). The coding region of AAV-2 is flanked by inverted
terminal repeat (ITR) sequences of 145 nt each. The ITRs contain all of
the cis-acting sequences required for DNA replication,
packaging, and integration. The AAV genome harbors two open reading
frames (ORFs) termed rep and cap that encode the
nonstructural and structural proteins, respectively. The cap
ORF encodes the viral capsid proteins (VP-1, VP-2, and VP-3). The
rep ORF is expressed from promoters at map positions 5 (p5)
and 19 (p19) and is translated into four overlapping nonstructural
proteins by alternative splicing (35, 49). The p5 proteins,
Rep78 and Rep68, have been shown to be required for AAV DNA
replication, integration, and gene regulation. The p5 Rep proteins
possess site- and strand-specific endonuclease, DNA ligase, ATPase, and
helicase activities, as well as the ability to specifically bind the
viral ITR in either a duplex or single-stranded conformation (26,
27, 55, 68). The p19 proteins, Rep52 and Rep40, lack the 224 N-terminal residues of Rep78 and Rep68, retain ATP-dependent helicase
activity (56), and appear to be involved in the
encapsidation of virus genomes (11, 18). While the
activities of Rep proteins that are required for viral replication are
well described, still relatively little is known regarding the
mechanisms by which Rep affects the cell. Although interaction of
several cellular proteins
such as the transcription factor Sp1
(24), the transcription cofactor PC4 (61),
high-mobility group nonhistone protein 1 (16), the
oncosuppressor p53 (4), and cyclic AMP-dependent protein
kinases PrKX and PKA (12, 17)
with Rep proteins has been
described, the consequences of these interactions for the cell remain
obscure. The effects of Rep expression on the phenotype of the cell
have been described anecdotally and include both retardation of cell
growth and cell death. Rep expression has been shown to inhibit
transformation by cellular and viral oncogenes and to repress cellular
and viral DNA replication through unknown processes (23, 29,
64). Studies with a cell line that inducibly expresses Rep have
demonstrated inhibition of cellular DNA synthesis and distortion of the
cell cycle (64, 65). The combination of Rep expression with
UV irradiation or incubation with cadmium induced cell death that
exhibited some of the characteristics of apoptosis (66, 67).
Apoptosis, or programmed cell death, is a highly regulated cellular
suicide process. It is involved in normal tissue development as well as
in the response of the cell to stress, growth factor deprivation, and
DNA damage. Morphological changes typical for apoptotic cells include
nuclear and cytoplasmatic condensation, which is followed by the
fragmentation of the cell into apoptotic bodies. In vivo, these cell
fragments are consumed by macrophages without the elicitation of an
inflammatory response (57, 60). Biochemical characteristics
include fragmentation of DNA, partial loss of plasma membrane
asymmetry, and reduction of the mitochondrial transmembrane potential.
Apoptosis can be triggered by external or cellular signals. Stimuli
from both pathways are integrated and amplified by a family of cysteine
proteases with aspartate specificity, referred to as caspases. Caspases
are expressed as zymogens, inactive proenzymes which are
proteolytically activated during the transduction of death signals.
Caspases by proteolytically cleaving vital cellular proteins, are also
involved in the execution of cell death. Among the caspase targets are
actin, lamins, and poly(ADP-ribose) polymerase (8, 19).
In this study, we showed that AAV-2 Rep78 expression is sufficient to
induce apoptosis as well as an accumulation of cells in the
G1 phase of the cell cycle. Apoptosis was mediated by
caspase-3 and was shown to be independent of p53. By analyzing the
effects of Rep mutations on cell viability, it was determined that cell death was attributable in part to the DNA binding and ATPase-helicase activities of Rep78. Surprisingly, the endonuclease activity of Rep78
did not contribute to apoptosis induction.
 |
MATERIALS AND METHODS |
Plasmids.
A plasmid expressing a nucleus-localized green
fluorescent protein (GFP), pNLS-GFP, was constructed by N-terminal
fusion of a sequence coding for the simian virus 40 large T antigen
nuclear localization signal PKKKRKV (28) to the GFP ORF of
pEGFP-N1 (Clontech, Palo Alto, Calif.) by PCR cloning. The GFP gene was amplified using pEGFP-N1 as template and 5'-GAG AAG ATC TCA CCA TGG GTC CTA AGA AGA AGC GTA AGG TGA GCA AGG GCG AGG AGC TGT-3' and 5'-CCT CTA CAA ATG TGG TAT GGC T-3' as primers.
The PCR product was digested with BglII and NotI
and inserted into BglII- and NotI-cut pEGFP-N1.
The plasmid pRep78-GFP, expressing a Rep78-GFP fusion protein, was
constructed by amplifying the Rep78 ORF from pAV2, a plasmid containing
the AAV-2 genome (34), using primers 5'-GAG GCT AGC CAC
CAT GGC CCC GGG GTT TTA CGA GAT T-3' and 5'-ACT GCT CGA GTT
GTT CAA AGA TGC AGT CAT C-3'. The PCR product was digested with
NheI and XhoI and inserted into NheI-
and XhoI-cut pEGFP-N1. pRep52-GFP was constructed
accordingly, using primers 5'-GAG GCT AGC CAC CAT GGA GCT GGT CGG
GTG GCT C-3' and 5'-ACT GCT CGA GTT GTT CAA AGA TGC AGT CAT
C-3' to amplify the Rep52 ORF from the pAV2 template. pRep78-GFP(K340H)
and pRep78-GFP(Y156F) were constructed by replacing the 1.2-kbp
NruI-KpnI fragment of pRep78-GFP with the
corresponding fragment of pMBP-Rep78 (NTP) (56), bearing a
K340H mutation, and pMBP-Rep78(Y156F) (55), respectively.
Cell lines.
HL60 human promyelocytic leukemia cells were
grown in suspension at densities between 2 × 105 and
1 × 106 cells/ml. The cells were maintained in RPMI
1640 medium supplemented with 10% fetal calf serum (FCS), 2 mM
L-glutamine, 100 U of penicillin/ml, and 0.1 mg of
streptomycin/ml. NTERA-2 (NT2) cells, a pluripotent human embryonal
carcinoma cell line, were maintained in Dulbecco's modified Eagle's
medium supplemented with 10% FCS, 1 mM pyruvate, 2 mM
L-glutamine, 100 U of penicillin/ml, and 0.1 mg of
streptomycin/ml. Cells were maintained at 37°C in a 5%
CO2 humidified atmosphere. Both cell lines were obtained
from the American Type Culture Collection (Manassas, Va.). Tissue
culture media and supplements were purchased from Life Technology
(Gaithersburg, Md.) and HyClone (Logan, Utah).
DNA transfection.
DNA transfection was performed by
electroporation with a 600R Electro Cell Manipulator (BTX, San Diego,
Calif.). Cells (2 × 106) were resuspended in 400 µl
of RPMI 1640 medium supplemented with 20% FCS and 40 µg of plasmid
DNA. Cells were pulsed in 0.4-cm-gap electrode cuvettes (Bio-Rad,
Hercules, Calif.) at 300 V and 1,050 µF (HL-60) or at 200 V and 1,050 µF (NT2).
Flow cytometric analysis of viability.
Cells were washed
with phosphate-buffered saline (PBS) and resuspended in 200 to 500 µl
of PBS containing 50 µg of propidium iodide (PI)/ml for staining of
dead cells. Cells were incubated for at least 10 min at room
temperature and analyzed using an Epics XL flow cytometer
(Beckman-Coulter, Fullerton, Calif.).
Flow cytometric analysis of apoptosis.
The quantitative
determination of cells undergoing apoptosis was done by an Annexin V
staining assay (BD PharMingen, San Diego, Calif.) according to the
manufacturer's instructions. Briefly, 5 × 105 cells
were washed with PBS and resuspended in 400 µl of Annexin V binding
buffer (10 mM HEPES-NaOH, pH 7.4; 140 mM NaCl; 2.5 mM CaCl2), and 15 µl of Annexin V-phycoerythrin was added.
The vital dye ViaProbe (BD PharMingen; 15 µl/400 µl) was used
to discriminate apoptotic cells (which are Annexin V positive and
ViaProbe negative) from necrotic and dead cells (which are Annexin V
positive and ViaProbe positive). Stained cells were analyzed by flow
cytometry after a 15-min incubation at room temperature. During data
collection, cells were gated by forward- and side-scatter analysis to
exclude cell debris. A minimum of 10,000 events were collected for each sample.
Flow cytometric analysis of DNA content.
DNA content of live
cells was determined by staining with the DNA dye Hoechst 33342 (Molecular Probes, Eugene, Oreg.) at a concentration of 10 µg/ml in
cell culture medium for 30 min at 37°C. After the incubation, cells
were washed in PBS and resuspended in 400 µl of Annexin V binding
buffer. A 15-µl aliquot of ViaProbe was added to discriminate living
from dead cells. DNA content analysis was done by flow cytometry
(Coulter EPICS Elite ESP). Cell debris and dead cells were excluded
from the analysis by forward- and side-scatter analysis and exclusion
of ViaProbe-positive (dead) cells. Data were analyzed with the ModFit
software (Verity Software House, Topsham, Maine).
Caspase-3 assay.
Cells transfected with pNLS-GFP or
pRep78-GFP were stained with 50-µg/ml PI and sorted by
fluorescence-activated cell sorting, using an EPICS Elite ESP flow
cytometer. Cells which were GFP positive (i.e., NLS-GFP- or
Rep78-GFP-expressing cells) and PI negative (living cells) were
collected. Sorted cells were washed in PBS and analyzed for caspase-3
activity by using a CPP32/caspase-3 colorimetric protease assay kit
(Chemicon, Temecula, Calif.) according to the instructions of the
manufacturer. Briefly, cells were lysed in 150 µl of cell lysis
buffer provided in the kit. Protein concentrations of the lysates were
determined by using the bicinchoninic acid assay reagent (Pierce,
Rockford, Ill.). Equal amounts of lysates were incubated with the
caspase-3 substrate, 200 µM DEVD-pNA, at 37°C for 3 h.
Absorbances of samples were read every 60 min in a Spectramax 250 (Molecular Dynamics) microplate reader at 405 nm. Caspase-3 activity
was proportional to the optical density at 405 nm.
Inhibition of caspase-3.
The caspase-3 inhibitor
Z-Asp-Glu-Val-Asp-fluoromethylketone (Z-DEVD-FMK) was obtained from
Calbiochem (San Diego, Calif.) and used at a final concentration of 100 µM. The inhibitor was added to the medium 1 h after
transfection. Half of the medium was exchanged every 24 h with
fresh medium containing 100 µM Z-DEVD-FMK.
 |
RESULTS |
AAV-2 Rep78 is cytotoxic.
AAV-2 Rep78 is a multifunctional
protein involved in AAV DNA replication, integration, and gene
regulation. Recent studies using an inducible Rep-expressing cell line
demonstrated that UV irradiation, incubation, with a heavy metal, and
Rep78 expression in various combinations resulted in cell death with
some characteristics of apoptosis and perturbation of the cell cycle
(65-67). The goal of the study reported here was to analyze
the effect of Rep78 on the cell in the absence of toxic chemicals and
other stressful condition. Rep78 was expressed transiently as an
N-terminal fusion protein with the GFP encoded by the plasmid
pRep78-GFP. The GFP tag allowed tracking of Rep78-expressing cells at
the single-cell level. Rep78-GFP retained the biochemical activities
necessary for AAV replication. We were able to complement a Rep78 frame shift mutant with Rep78-GFP for the production of recombinant AAV (data
not shown). To determine if Rep78 expression was sufficient to induce
cytotoxicity, pRep78-GFP and the control plasmid pNLS-GFP, encoding a
nucleus-localized GFP, were transfected separately into HL-60 cells, a
human promyelocytic leukemia cell line. Expression of Rep78-GFP and
NLS-GFP was detectable by fluorescence microscopy as early as 3 h
posttransfection; the transfection efficiency was typically found to be
in the range of 20 to 60% (data not shown). At various time points,
cells were analyzed for viability by PI staining and flow cytometry
(Fig. 1). The staining of cells with the
vital dye PI is commonly used to quantify cell death. This method is
based on the ability of live cells with intact cytoplasmic membranes to
exclude PI while dead cells, with compromised cytoplasmic membranes,
are unable to exclude this dye and are stained by the formation of a
fluorescent PI-DNA complex (36). Figure 1 shows that about
25% of Rep78-GFP-expressing cells were dead at 24 h and that
about 50% were dead at 48 h posttransfection. The observed
cytotoxicity was not due to the GFP tag of Rep78-GFP, since only a
minor reduction in cell viability (4% at 48 h posttransfection) was detected in cells expressing NLS-GFP.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Rep78 expression is cytotoxic. The viability of
pNLS-GFP- or pRep78-GFP-transfected HL-60 cells was determined by PI
staining (50 µg/ml) and flow cytometry. Percent viability represents
the fraction of cells that excluded PI times 100. The abscissa is the
time after electroporation. , pNLS-GFP; , pRep78-GFP.
|
|
Rep78-mediated cytotoxicity results from apoptosis.
Our
results indicate that Rep78 expression is sufficient to cause
cytotoxicity. Cell death occurs by either necrotic or apoptotic pathways (38). Necrosis is a passive process usually
observed after chemical or mechanical injury of the cell. It is
characterized by cell swelling and early membrane rupture. Apoptosis is
an active process that is highly regulated and is characterized by
cellular shrinkage and nuclear condensation. An early event in cells
undergoing apoptosis is the partial loss of phospholipid asymmetry,
leading to the translocation of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane. Since the membrane integrity is not affected by this rearrangement, apoptotic cells exclude vital dyes. The exposure of PS can be detected with
fluorescently labeled Annexin V, a phospholipid binding protein that
has a high affinity for PS (31). To discriminate between
apoptotic and necrotic cells, ViaProbe was used as a costain. ViaProbe
is a cell membrane-impermeable nucleic acid dye which stains only dead and necrotic cells with compromised membrane integrity (52). Annexin V analysis by flow cytometry of pRep78-GFP- or
pNLS-GFP-transfected HL-60 cells showed a correlation between Annexin
V-positive cells and Rep78-expressing cells, indicating that Rep78
induced cell death by apoptosis (Fig. 2A and
B). In a time course experiment, we
observed an increase of apoptotic Rep78-expressing cells from 14% at
6 h posttransfection to 29% at 36 h (Fig. 2C). During
this time period, we noticed an increase of nonviable
Rep78-GFP-expressing cells of from 1 to 48% (Fig. 1). The percentage
of Annexin V-positive, NLS-GFP-expressing cells remained relatively
constant over time at about 10% in the pNLS-GFP-transfected cultures
(Fig. 2C), while we noticed a slight (1 to 3.7%) increase in dead
cells (Fig. 1).


View larger version (72K):
[in this window]
[in a new window]
|
FIG. 2.
Rep78 induces apoptosis. Shown are representative
diagrams of Annexin V staining of pNLS-GFP-transfected (A) or
pRep78-GFP-transfected (B) HL-60 cells at 24 h posttransfection.
The x axis represent the green fluorescence intensity
(NLS-GFP expression in panel A and Rep78-GFP expression in panel B).
The fluorescence intensity of Annexin V-PE is represented on the
y axis. The populations in the upper quadrants are apoptotic
cells, while cells in the lower quadrants are nonapoptotic. Left
quadrants are GFP-negative cells, while cells in the right quadrants
are those expressing NLS-GFP (A) or Rep78-GFP (B). Cells displayed were
gated for the exclusion of ViaProbe (i.e., dead cells). The percentage
of Rep78-mediated apoptosis was calculated by division of the
percentage of Annexin V-positive, Rep78-GFP-expressing cells by the
percentage of the total Rep78-GFP subpopulation [9.3%/(9.3% + 23.6%) = 28.2%]. (C) Time course of induction of apoptosis by
Rep78. Data are means ± standard errors of values from three
experiments. Percent apoptosis was determined as in described for panel
B.
|
|
Rep78 expression activates caspase-3.
Apoptotic signals from
membrane-associated receptors and mitochondrial sensors converge on a
common pathway, the caspases (8). Caspases are a family of
cysteine proteases which integrate and amplify death signals and also
mediate cell death. Caspase-3 is a terminal caspase involved in the
execution of cell death by proteolytic cleavage of essential cellular
proteins. Among the targets of caspase-3 are poly(ADP-ribose)
polymerase, lamins, and gesolin (19). Caspase-3 activation
during apoptosis induced by infection with human immunodeficiency virus
type 1 (HIV-1) (2), Sendai virus (6), parvovirus
B19 (42), and adenovirus (13) has been described.
We investigated the involvement of caspase-3 in Rep78-induced
apoptosis. Caspase-3 activity in the lysates of pNLS-GFP- or
pRep78-GFP-transfected cells was measured. At 12 h
posttransfection, a substantial increase of caspase-3 activity in
Rep78-expressing cells relative to NLS-GFP-expressing cells was
observed (Fig. 3). These results indicate
that Rep78 expression activates caspase-3 and that Rep78-induced
apoptosis is mediated at least in part by caspase-3.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Rep78 expression results in activation of caspase-3.
pNLS-GFP- or pRep78-GFP transfected HL-60 cells were stained with PI
and sorted by flow cytometry for the expression of GFP or Rep78-GFP and
exclusion of PI (i.e., living cells) at 12 h posttransfection.
Extracts of sorted cells were assayed for caspase-3 activity toward the
substrate DEVD-pNA. Caspase-3 activity is proportional to the optical
density (OD) at 405 nm. Data are means ± standard errors of
values from three experiments.
|
|
Inhibition of Rep78-induced apoptosis by inhibition of
caspase-3.
Since Rep78 expression resulted in activation of
caspase-3, we explore whether caspase-3 activation was essential for
Rep78-induced apoptosis by studying the effects of a caspase-3
inhibitor. HL-60 cells transfected with pRep78-GFP or pNLS-GFP were
treated with the peptidic inhibitor of caspase-3, Z-DEVD-FMK
(45). Cells were assayed for apoptosis by costaining with
Annexin V-PE and ViaProbe prior to flow cytometry. While incubation
with Z-DEVD-FMK resulted in a slight increase in the number of
apoptotic cells in pNLS-GFP-transfected cells (Fig.
4), we noted a decrease of Annexin
V-positive, Rep78-GFP-expressing cells after treatment with Z-DEVD-FMK,
to the level of NLS-GFP-expressing cells at 36 h posttransfection.
Thus, incubation with Z-DEVD-FMK efficiently inhibited Rep78-mediated
apoptosis. From these results we conclude that Rep78-induced apoptosis
in HL-60 cells is dependent on caspase-3 activity. Incubation with
Z-DEVD-FMK also led to an increase in expression levels in pNLS-GFP-
and in pRep78-GFP-transfected cells (data not shown), which might have
led to a slightly increased toxicity compared to that of
non-Z-DEVD-FMK-treated cells observed at early time points.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
The synthetic peptide inhibitor Z-DEVD-FMK reduced
levels of Rep78-induced apoptosis. HL-60 cells were transfected with
pNLS-GFP or pRep78-GFP. The caspase-3 inhibitor Z-DEVD-FMK (100 µM)
was added 1 h after transfection and was present throughout the
experiment. Cells were analyzed for apoptosis by Annexin V staining and
flow cytometry. Data are means ± standard errors of values from
three experiments. , pNLS-GFP; , pNLS-GFP plus Z-DEVD-FMK; ,
pRep78-GFP; , pRep78-GFP plus Z-DEVD-FMK.
|
|
Rep78 expression results in an accumulation of cells in
G1.
Since deregulation of the cell cycle may be
involved in the induction of apoptosis (30), we investigated
the effects of Rep78 expression on cell cycle progression in HL-60
cells. The DNA content of cells transfected with pNLS-GFP or pRep78-GFP
was determined 12 h posttransfection by staining with Hoechst
33342 and performing flow cytometry (Fig.
5). Hoechst 33342 is a cytoplasmic membrane-permeative DNA dye which can be used for DNA staining without
fixation of the cells (53). Analysis of the DNA content of
pNLS-GFP-transfected cells showed that the patterns of cell cycle
distribution were similar in NLS-GFP-expressing cells (Fig. 5A, right
panel) and in non-NLS-GFP-expressing cells (Fig. 5A, left panel),
indicating that NLS-GFP expression had no effect on cell cycle
progression. In contrast, Rep78 expression resulted in a dramatic
alteration of the cell cycle. We observed an accumulation of cells in
G1 (Fig. 5B, right panel) in the Rep78-GFP-expressing subpopulation of pRep78-GFP-transfected cells (73.9% of cells in
G1, versus 43.3% in pRep78-GFP-transfected,
non-Rep78-GFP-expressing cells) that was accompanied by a reduction of
cell numbers in the S and G2/M phases.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 5.
Rep78 expression results in an accumulation of cells in
the G1 phase of the cell cycle. Twelve hours after
transfection of HL-60 cells with pNLS-GFP (A) or pRep78-GFP (B), the
cell cycle distribution was analyzed by staining for DNA content with
the dye Hoechst 33342. Diagrams on the right show cells [GFP(+)]
which have been gated for GFP expression (i.e., NLS-GFP in panel A and
Rep78-GFP in panel B, whereas those on the left [GFP( )] show data
for GFP-negative cells. Dead cells detected by ViaProbe staining were
excluded from this analysis.
|
|
Rep78-induced apoptosis is cell cycle specific.
To
determine whether the observed Rep78-induced accumulation of cells in
G1 was due to cell cycle arrest at the G1/S
checkpoint or to a selective killing of cells in the S or
G2/M phase of the cell cycle, we analyzed whether apoptosis
upon Rep78 expression was cell cycle specific. pRep78-GFP-transfected
HL-60 cells were analyzed 12 h posttransfection for apoptosis by
Annexin V staining and, simultaneously, for DNA content by incubation
with the dye Hoechst 33342 (44). Figure
6 shows that apoptotic cells accumulated in the G1 and early S phases of Rep78-GFP-expressing cells.
The observed accumulation of cells in G1 after Rep78
expression cannot be explained by a selective killing of cells in
G2; a Rep78-induced cell cycle block at the
G1/S checkpoint therefore appears more likely to be the
cause of accumulation of cells in G1.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 6.
Rep78-induced apoptosis is G1/early-S-phase
specific. HL-60 cells were transfected with pRep78-GFP. Twelve hours
after transfection, cells were analyzed for DNA content by staining
with the dye Hoechst 33342 (x axis) and for apoptosis by
Annexin V staining (y axis). Cells analyzed were gated for
expression of Rep78-GFP [GFP(+); right panel) or nonexpression
[GFP( ); left panel). Cells in the left quadrants of the panels are
in G1 or early S phase, and cells in the right quadrants
are in late S or G2/M phase of the cell cycle. The upper
quadrants of each panel represent apoptotic cells, while the lower
quadrants show nonapoptotic cells. Dead cells were excluded from this
analysis by costaining with ViaProbe. Data shown are for cells which
had been gated for size, granularity, and exclusion of ViaProbe.
|
|
The ATPase activity of Rep78 is critical for the cytotoxic
effect.
The biochemical properties of Rep78 include DNA binding,
endonuclease, ATPase, and helicase activities. To investigate the contributions of these activities to cytotoxicity, we analyzed the
abilities of a series of Rep mutants to induce cell death (Fig.
7). The tyrosine residue at position 156 of Rep78 is necessary for transesterification, and a phenylalanine
substitution at this position causes a deficiency in DNA strand
cleavage (55). Transfection with pRep78(Y156F)-GFP resulted
in no change in cytotoxicity compared to wild-type Rep78-GFP,
indicating that DNA cleavage does not contribute significantly to
Rep78-induced cytotoxicity. Rep52-GFP, lacking the 224 N-terminal
residues of Rep78 including the DNA binding domain, showed an
intermediate level of cytotoxicity, while a disruption of the
nucleoside triphosphate binding domain of Rep78 in
pRep78(K340H)-GFP which resulted in the loss of ATPase and helicase
activities (56, 62) was most efficient at suppressing the
cytotoxicity of Rep78, although complete abrogation of cell death was
not observed. These results are summarized in Table 1. Rep-GFP expression was analyzed by
Western blot analysis and by monitoring the GFP fluorescence intensity.
Rep78-GFP, Rep78(K340H)-GFP, and Rep78(Y156F)-GFP were expressed at
similar levels, while the level of expression of Rep52-GFP was found to
be significantly higher (about twofold) than that of Rep78-GFP (data
not shown).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 7.
Mutation of the ATP binding site of Rep78 reduces
cytotoxicity. The viability of pNLS-GFP-, pRep78-GFP-,
pRep78(Y156F)-GFP-, or pRep78(K340H)-GFP-transfected HL-60 cells
was assayed by PI staining (50 µg/ml) and flow cytometry. Data are
means ± standard errors of values from three experiments. ,
pNLS-GFP; , pRep78-GFP; , pRep78(Y156F)-GFP; ,
pRep78(K340H)-GFP; , pRep52-GFP.
|
|
Induction of apoptosis by Rep78 is not confined to HL-60 cells and
is independent of p53.
The data presented so far demonstrate that
Rep78 induces apoptosis in HL-60 cells, a p53-null promyeloid cell line
(15). To determine whether this ability is confined to this
cell type, we analyzed the effect of Rep78 expression on NT2 cells, a
wild-type p53-containing embryonal carcinoma cell line (9).
Annexin V staining of pRep78-GFP-transfected cells revealed that 43%
of Rep78-GFP-expressing NT2 cells underwent apoptosis by 24 h
posttransfection (Fig. 8A). A time course
experiment showed that the percentage of Rep78-expressing cells
undergoing apoptosis between 10 to 24 h posttransfection increased
from 17% to about 40%, while cells transfected with pNLS-GFP showed
only background levels of Annexin V-positive cells (Fig. 8B). Apoptosis
and viability correlated inversely. Apoptosis in Rep78-GFP-expressing
NT2 cells resulted in cell death. These results demonstrate that Rep78
induces apoptosis in cells of different lineage, independently of p53.


View larger version (60K):
[in this window]
[in a new window]
|
FIG. 8.
Rep78 induces apoptosis in NT2 cells. NT2 cells were
transfected with pNLS-GFP or pRep78-GFP and analyzed for apoptosis by
Annexin V staining. (A) Representative data for cells at 24 h
posttransfection. The x axis represents the green
fluorescence intensity (i.e., NLS-GFP or Rep78-GFP). The fluorescence
intensity of Annexin V-PE is represented on the y axis. The
populations in the upper quadrants show apoptotic cells, while cells in
the lower quadrants are nonapoptotic. Cells were gated for the
exclusion of ViaProbe (i.e., dead cells). (B) Time course of the
experiment shown in panel A.
|
|
 |
DISCUSSION |
In this study, we demonstrated that AAV Rep78 is cytotoxic and
cytostatic. Cell death is induced by apoptosis, independently of p53
and mediated by caspase-3. Rep78 expression was also accompanied by an
accumulation of cells in the G1 phase of the cell cycle.
The majority of experiments analyzing the cytotoxicity of Rep78 have
been done with inducible stable cell lines which either require a toxic
heavy metal for induction of expression (65-67) or have
shown low-level expression (25). We established a new system
to study the effects of Rep78 on the cell by fusing the ORF of the
autofluorescent peptide GFP to Rep78. This allowed tracking of Rep78
expression on a single-cell level. Using this system, we were able to
demonstrate that Rep78 is highly cytotoxic: 50% of Rep78-expressing
cells died within 48 h posttransfection. Cell death can be caused
by two different pathways, apoptosis and necrosis (38).
Apoptosis, or programmed cell death, is an active, highly regulated
process characterized by morphological and biochemical changes. In an
early event, an outer-membrane leaflet inversion leads to exposure of
PS. Nuclear and cytoplasmic condensation is followed by fragmentation
of the cell and breakdown of the nuclear membrane (57, 60).
Necrosis is characterized by a rapid loss of membrane integrity and
cell swelling followed by a collapse of the cell. In vivo, apoptotic
cell death is reported to be noninflammatory while necrotic death is
typically accompanied by inflammation (41). In HL-60 cells,
a p53-null promonocyte cell line, we observed a correlation
between Rep78 expression and detection of the apoptosis-specific
loss of membrane asymmetry. Apoptosis in Rep78-expressing cells was
detectable very early after transfection, and its level increased over
time. During the same time period we noticed an increase of nonviable
Rep78-expressing cells. Induction of apoptosis by Rep78 was not
restricted to the p53-negative cell line HL-60 but was also observed in
the wild-type p53-containing embryonal carcinoma cell line NT2. These
results demonstrate that Rep78 is cytotoxic, inducing apoptosis
independently of p53.
In this study we addressed the characteristics and molecular mechanism
of Rep-induced cell death. Caspases are involved in the transduction
and amplification of apoptotic signals from different pathways as well
as in the execution of cell death. We analyzed the function of
caspase-3 in Rep-induced apoptosis. Caspase-3 is a terminal caspase
which is activated by a variety of different stimuli and is involved in
the execution of cell death via cleavage of critical cellular proteins
such as poly(ADP-ribose) polymerase, lamins, and gelsolin
(19). Expression of Rep78 in HL-60 cells resulted in the
activation of caspase-3. Furthermore, incubation of Rep78-expressing
cells with the peptidic caspase-3 inhibitor Z-DEVD-FMK efficiently
inhibited apoptosis. These findings demonstrate that Rep78 induces
apoptosis by a caspase-3-dependent pathway. The involvement of
caspase-3 activation in the apoptosis induced by infection with HIV
(2), adenovirus (13) and Sendai virus (6) has also been shown.
Recent studies suggest that apoptosis and the cell cycle are connected
(7, 22). Apoptotic stimuli affect both cell proliferation and death (30). We therefore analyzed the effect of Rep78 on cell cycle progression. We observed an accumulation of cells in the
G1 phase upon Rep78 expression compared to nontransfected or control cells and a decrease of cells in S and G2/M.
Rep78-induced apoptosis was shown to be specific for cells in the
G1 and early S phases of the cell cycle by staining of
Rep-expressing cells simultaneously with Hoechst 33342 for DNA content
and with Annexin V for detection of apoptosis. This result indicates
that Rep-induced apoptosis may be dependent on factors specific for
these cell cycle phases. It also implies that the accumulation of
Rep78-expressing cells in G1 is due to a cell cycle block
at the G1/S checkpoint rather than to a selective killing
of cells in S and G2. The observed effects of Rep78 on cell
survival and cell cycle progression in this transient system differ
from the data obtained with stable Rep-inducible cell lines. Holscher
et al. (25) described a stable HeLa cell line expressing Rep
under the control of the glucocorticoid-responsive mouse mammary tumor
virus promoter. Upon induction, no cytotoxic or antiproliferative
effect of Rep was detected. Yang et al. (65) described
293-based cell lines that express the AAV Rep proteins under the
control of an inducible mouse metallothionein transcription promoter.
Upon induction with heavy metals, an accumulation of Rep-expressing
cells in S phase was observed, but no toxicity was reported. However,
Rep enhanced the toxicity of UV irradiation and incubation with cadmium
(66, 67). These differences in the effect of Rep on the cell
may be due to the cell types used for the studies, expression
efficiencies of the rep gene, and adaptation of the cell
lines to background levels of Rep expression or alterations in the
genomic rep gene. 293 cells contain a colinear segment from
human adenovirus type 5, from nt 1 to 4344, which is integrated into
chromosome 19 (19q13.2) (37). This segment contains the
E1A-E1B region of the adenovirus genome. The E1A gene products bind to
key elements such as members of the pRB family, inducing unscheduled
cell cycle progression. The E1B-55K protein was shown to bind and
inhibit p53, while E1B-19K acts as a Bcl-2 homolog in inhibiting
apoptosis (3). HeLa cells are a cervical-carcinoma-derived
cell line containing multiple copies of integrated human papillomavirus
(HPV) type 18 DNA (40). HPV type 18 encodes regulators of
cell cycle progression and apoptosis which act similarly to the
adenovirus-encoded E1 proteins (3). The viral gene products
of both cell lines are likely to modulate the effect of Rep on the cell
cycle and apoptosis and may explain the differences observed in the
different systems. In addition, an effect of the inducers of the stable
Rep-expressing cell lines on cell growth and death is possible. Yang et
al. used zinc and cadmium to induce Rep expression. Cadmium is a highly
toxic heavy metal that has been shown to induce distortion of the cell
cycle (48) and apoptosis by causing oxidative stress and DNA
damage (1); zinc, in contrast, is efficient at inhibiting
apoptosis (39, 58). The transient Rep expression system
described in this study may be advantageous for profiling the effects
of Rep on the cell compared to the stable Rep-expressing cell line,
since no chemical inducers are required and alterations of cell
physiology due to background levels of Rep expression and clonal
selection can be excluded.
Our findings show an interesting analogy between the effects of AAV-2
Rep78 and the nonstructural protein (NS-1) of the autonomous parvoviruses on the cell. Both proteins possess cytostatic and cytotoxic potential. Cell death caused by NS-1 expression was induced
by apoptosis (10) which was mediated by and dependent on
caspase-3 (42). The cytostatic potential of NS-1 correlated with an accumulation of cells in G2 (46) and a
block in cellular DNA replication which was proposed to be a
consequence of NS-1-induced DNA damage (47).
Apoptosis can be induced by a variety of stimuli, including DNA damage,
nutrient deprivation, hypoxia, and cytokines of the tumor necrosis
factor family (8, 63). In addition, virus infection may
trigger apoptosis of the infected cell (50). Several viral
gene products are associated with apoptosis induction; adenovirus E1A,
simian virus 40 large T antigen, and HPV type 18 E7 protein mediate
apoptosis by inducing unscheduled DNA synthesis (59). HIV-1
gp120 and Sindbis virus E2 cause programmed cell death by receptor
signaling, and human T-cell leukemia virus type 1 Tax causes apoptosis
via transcriptional dysregulation of the cell (20). In
addition, oxidative stress and overload of the endoplasmic reticulum as
a consequence of viral replication have been shown to be inducers of
cell death (20, 50). Apoptosis induced by viruses can be
seen as a mechanism for viral release while limiting the inflammatory
and immune responses (59) or as an innate immune response of
the cell to the viral infection (14). We started to
determine the mechanism of Rep-induced apoptosis. The biochemical activities of Rep are characterized as ATPase, helicase, endonuclease, ligase, and DNA binding protein. These functions are required for viral
DNA replication, integration, and gene regulation. In addition, Rep has
been shown to interact with the cellular proteins SP-1, PC4, p53, and
high-mobility group nonhistone protein 1 (4, 16, 24, 61).
Rep78 and Rep52 bind and inhibit protein kinases PKA and PrKX (12,
17). The mechanism of Rep-mediated cell death may involve any one
or a combination of Rep's biochemical activities and interactions with
cell proteins. In this study, by analyzing the cytotoxicity of Rep
mutants, we examined the biochemical activities of Rep that contribute
to cell death. The mutation of the endonuclease activity in
pRep78(Y156F)-GFP resulted in no change in toxicity compared to that of
wild-type Rep78. This indicates that Rep78 is not inducing apoptosis
directly by causing DNA damage. Rep52, which lacks the 224 N-terminal
residues of Rep78, is an ATP-dependent helicase but lacks specific DNA binding activity; its toxicity was 23% lower than that of p78, while
the mutation of the nucleotide binding site in pRep78(K340H)-GFP resulted in a 53% lower level of induction of cell death. The mutation
in Rep78(K340H) resulted in a loss of ATPase and helicase activities,
while the specific DNA binding activity and the endonuclease activity
were not affected. Taken together, these results suggest that Rep78
induces apoptosis by multiple mechanisms. The major determinant of
toxicity appears to be linked to the ability of Rep to hydrolyze ATP.
The ATPase activity of Rep has been shown to be constitutively active
and independent of a DNA substrate (68). Overexpression of
Rep may therefore lead to a partial depletion of the cellular ATP pool,
an occurrence that is known to trigger apoptosis (21). The
helicase activity may adversely affect DNA synthesis or transcription.
Interestingly, the toxicity of the related NS-1 protein of human
parvovirus B19 has been demonstrated to be dependent on ATPase activity
as well (43). The remaining toxicity of Rep78(K340H)
suggests the existence of an additional ATPase- and
helicase-independent mechanism of induction of cell death which appears
to be coupled to the specific DNA binding and gene regulation domain of
Rep. Further studies will analyze the mechanism and pathway of
Rep-induced apoptosis in more detail.
 |
ACKNOWLEDGMENTS |
We thank Martha Kirby for expert assistance with flow cytometry
and helpful discussions and Richard Smith for a critical review of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: LBG, NHLBI,
Bldg. 10, Rm. 7D05, Bethesda, MD 20892-1654. Phone: (301) 496-1594. Fax: (301) 496-9985. E-mail: KotinR{at}NHLBI.NIH.GOV.
 |
REFERENCES |
| 1.
|
Bagchi, D.,
S. S. Joshi,
M. Bagchi,
J. Balmoori,
E. J. Benner,
C. A. Kuszynski, and S. J. Stohs.
2000.
Cadmium- and chromium-induced oxidative stress, DNA damage, and apoptotic cell death in cultured human chronic myelogenous leukemic K562 cells, promyelocytic leukemic HL-60 cells, and normal human peripheral blood mononuclear cells.
J. Biochem. Mol. Toxicol.
14:33-41[CrossRef][Medline].
|
| 2.
|
Banki, K.,
E. Hutter,
N. J. Gonchoroff, and A. Perl.
1998.
Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase.
J. Biol. Chem.
273:11944-11953[Abstract/Free Full Text].
|
| 3.
|
Barry, M., and G. McFadden.
1998.
Apoptosis regulators from DNA viruses.
Curr. Opin. Immunol.
10:422-430[CrossRef][Medline].
|
| 4.
|
Batchu, R. B.,
M. A. Shammas,
J. Y. Wang, and N. C. Munshi.
1999.
Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition.
Cancer Res.
59:3592-3595[Abstract/Free Full Text].
|
| 5.
|
Berns, K. I.
1990.
Parvovirus replication.
Microbiol. Rev.
54:316-329[Abstract/Free Full Text].
|
| 6.
|
Bitzer, M.,
F. Prinz,
M. Bauer,
M. Spiegel,
W. J. Neubert,
M. Gregor,
K. Schulze-Osthoff, and U. Lauer.
1999.
Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32).
J. Virol.
73:702-708[Abstract/Free Full Text].
|
| 7.
|
Brady, H. J., and G. Gil-Gomez.
1999.
The cell cycle and apoptosis.
Results Probl. Cell Differ.
23:127-144[Medline].
|
| 8.
|
Budihardjo, I.,
H. Oliver,
M. Lutter,
X. Luo, and X. Wang.
1999.
Biochemical pathways of caspase activation during apoptosis.
Annu. Rev. Cell Dev. Biol.
15:269-290[CrossRef][Medline].
|
| 9.
|
Burger, H.,
K. Nooter,
A. W. Boersma,
C. J. Kortland, and G. Stoter.
1998.
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
Br. J. Cancer
77:1562-1567[Medline].
|
| 10.
|
Caillet-Fauquet, P.,
M. Perros,
A. Brandenburger,
P. Spegelaere, and J. Rommelaere.
1990.
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins.
EMBO J.
9:2989-2995[Medline].
|
| 11.
|
Chejanovsky, N., and B. J. Carter.
1989.
Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor.
Virology
171:239-247[CrossRef][Medline].
|
| 12.
|
Chiorini, J. A.,
B. Zimmermann,
L. Yang,
R. H. Smith,
A. Ahearn,
F. Herberg, and R. M. Kotin.
1998.
Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2.
Mol. Cell. Biol.
18:5921-5929[Abstract/Free Full Text].
|
| 13.
|
Chiou, S. K., and E. White.
1998.
Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection.
Virology
244:108-118[CrossRef][Medline].
|
| 14.
|
Clouston, W. M., and J. F. Kerr.
1985.
Apoptosis, lymphocytotoxicity and the containment of viral infections.
Med. Hypotheses
18:399-404[CrossRef][Medline].
|
| 15.
|
Collins, S. J.
1987.
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression.
Blood
70:1233-1244[Abstract/Free Full Text].
|
| 16.
|
Costello, E.,
P. Saudan,
E. Winocour,
L. Pizer, and P. Beard.
1997.
High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression.
EMBO J.
16:5943-5954[CrossRef][Medline].
|
| 17.
|
Di Pasquale, G., and S. N. Stacey.
1998.
Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation.
J. Virol.
72:7916-7925[Abstract/Free Full Text].
|
| 18.
|
Dubielzig, R.,
J. A. King,
S. Weger,
A. Kern, and J. A. Kleinschmidt.
1999.
Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes.
J. Virol.
73:8989-8998[Abstract/Free Full Text].
|
| 19.
|
Earnshaw, W. C.,
L. M. Luis,
M. Martins, and S. H. Kaufmann.
1999.
Mammalian caspases: structure, activation, substrates, and functions during apoptosis.
Annu. Rev. Biochem.
68:383-424[CrossRef][Medline].
|
| 20.
|
Everett, H., and G. McFadden.
1999.
Apoptosis: an innate immune response to virus infection.
Trends Microbiol.
7:160-165[CrossRef][Medline].
|
| 21.
|
Feldenberg, L. R.,
S. Thevananther,
M. del Rio,
M. de Leon, and P. Devarajan.
1999.
Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells.
Am. J. Physiol.
276:F837-F846[Abstract/Free Full Text].
|
| 22.
|
Gil-Gomez, G.,
A. Berns, and H. J. Brady.
1998.
A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis.
EMBO J.
17:7209-7218[CrossRef][Medline].
|
| 23.
|
Hermonat, P. L.
1989.
The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus.
Virology
172:253-261[CrossRef][Medline].
|
| 24.
|
Hermonat, P. L.,
A. D. Santin, and R. B. Batchu.
1996.
The adeno-associated virus Rep78 major regulatory/transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect.
Cancer Res.
56:5299-5304[Abstract/Free Full Text].
|
| 25.
|
Hölscher, C.,
M. Hörer,
J. A. Kleinschmidt,
H. Zentgraf,
A. Bürkle, and R. Heilbronn.
1994.
Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants.
J. Virol.
68:7169-7177[Abstract/Free Full Text].
|
| 26.
|
Im, D.-S., and N. Muzyczka.
1990.
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.
Cell
61:447-457[CrossRef][Medline].
|
| 27.
|
Im, D.-S., and N. Muzyczka.
1992.
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.
J. Virol.
66:1119-1128[Abstract/Free Full Text].
|
| 28.
|
Kalderon, D.,
B. L. Roberts,
W. D. Richardson, and A. E. Smith.
1984.
A short amino acid sequence able to specify nuclear location.
Cell
39:499-509[CrossRef][Medline].
|
| 29.
|
Khleif, S. N.,
T. Myers,
B. J. Carter, and J. P. Trempe.
1991.
Inhibition of cellular transformation by the adeno-associated virus rep gene.
Virology
181:738-741[CrossRef][Medline].
|
| 30.
|
King, K. L., and J. A. Cidlowski.
1998.
Cell cycle regulation and apoptosis.
Annu. Rev. Physiol.
60:601-617[CrossRef][Medline].
|
| 31.
|
Koopman, G.,
C. P. Reutelingsperger,
G. A. Kuijten,
R. M. Keehnen,
S. T. Pals, and M. H. van Oers.
1994.
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
Blood
84:1415-1420[Abstract/Free Full Text].
|
| 32.
|
Kotin, R. M.,
J. C. Menninger,
D. C. Ward, and K. I. Berns.
1991.
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter.
Genomics
10:831-834[CrossRef][Medline].
|
| 33.
|
Kotin, R. M.,
M. Siniscalco,
R. J. Samulski,
X. D. Zhu,
L. Hunter,
C. A. Laughlin,
S. McLaughlin,
N. Muzyczka,
M. Rocchi, and K. I. Berns.
1990.
Site-specific integration by adeno-associated virus.
Proc. Natl. Acad. Sci. USA
87:2211-2215[Abstract/Free Full Text].
|
| 34.
|
Laughlin, C. A.,
J. D. Tratschin,
H. Coon, and B. J. Carter.
1983.
Cloning of infectious adeno-associated virus genomes in bacterial plasmids.
Gene
23:65-73[CrossRef][Medline].
|
| 35.
|
Laughlin, C. A.,
H. Westphal, and B. J. Carter.
1979.
Spliced adenovirus-associated virus RNA.
Proc. Natl. Acad. Sci. USA
76:5567-5571[Abstract/Free Full Text].
|
| 36.
|
Loo, D. T., and J. R. Rillema.
1998.
Measurement of cell death.
Methods Cell Biol.
57:251-264[Medline].
|
| 37.
|
Louis, N.,
C. Evelegh, and F. L. Graham.
1997.
Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line.
Virology
233:423-429[CrossRef][Medline].
|
| 38.
|
McConkey, D. J.
1998.
Biochemical determinants of apoptosis and necrosis.
Toxicol. Lett.
99:157-168[CrossRef][Medline].
|
| 39.
|
Meerarani, P.,
P. Ramadass,
M. Toborek,
H. C. Bauer,
H. Bauer, and B. Hennig.
2000.
Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor alpha.
Am. J. Clin. Nutr.
71:81-87[Abstract/Free Full Text].
|
| 40.
|
Meissner, J. D.
1999.
Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines.
J. Gen. Virol.
80:1725-1733[Abstract].
|
| 41.
|
Melcher, A.,
M. Gough,
S. Todryk, and R. Vile.
1999.
Apoptosis or necrosis for tumor immunotherapy: what's in a name?
J. Mol. Med.
77:824-833[CrossRef][Medline].
|
| 42.
|
Moffatt, S.,
N. Yaegashi,
K. Tada,
N. Tanaka, and K. Sugamura.
1998.
Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells.
J. Virol.
72:3018-3028[Abstract/Free Full Text].
|
| 43.
|
Momoeda, M.,
S. Wong,
M. Kawase,
N. S. Young, and S. Kajigaya.
1994.
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.
J. Virol.
68:8443-8446[Abstract/Free Full Text].
|
| 44.
|
Moore, A.,
C. J. Donahue,
K. D. Bauer, and J. P. Mather.
1998.
Simultaneous measurement of cell cycle and apoptotic cell death.
Methods Cell Biol.
57:265-278[Medline].
|
| 45.
|
Nicholson, D. W.,
A. Ali,
N. A. Thornberry,
J. P. Vaillancourt,
C. K. Ding,
M. Gallant,
Y. Gareau,
P. R. Griffin,
M. Labelle,
Y. A. Lazebnik, et al.
1995.
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
Nature
376:37-43[CrossRef][Medline].
|
| 46.
|
Op De Beeck, A.,
F. Anouja,
S. Mousset,
J. Rommelaere, and P. Caillet-Fauquet.
1995.
The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2.
Cell Growth Differ.
6:781-787[Abstract].
|
| 47.
|
Op De Beeck, A., and P. Caillet-Fauquet.
1997.
The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin?
J. Virol.
71:5323-5329[Abstract].
|
| 48.
|
Payette, Y.,
M. Lachapelle,
C. Daniel,
J. Bernier,
M. Fournier, and K. Krzystyniak.
1995.
Decreased interleukin-2 receptor and cell cycle changes in murine lymphocytes exposed in vitro to low doses of cadmium chloride.
Int. J. Immunopharmacol.
17:235-246[CrossRef][Medline].
|
| 49.
|
Redemann, B. E.,
E. Mendelson, and B. J. Carter.
1989.
Adeno-associated virus Rep protein synthesis during productive infection.
J. Virol.
63:873-882[Abstract/Free Full Text].
|
| 50.
|
Roulston, A.,
R. C. Marcellus, and P. E. Branton.
1999.
Viruses and apoptosis.
Annu. Rev. Microbiol.
53:577-628[CrossRef][Medline].
|
| 51.
|
Samulski, R. J.,
X. Zhu,
X. Xiao,
J. D. Brook,
D. E. Housman,
N. Epstein, and L. A. Hunter.
1991.
Targeted integration of adeno-associated virus (AAV) into human chromosome 19.
EMBO J.
10:3941-3950[Medline]. (Erratum, 11:1228, 1992.)
|
| 52.
|
Schmid, I.,
W. J. Krall,
C. H. Uittenbogaart,
J. Braun, and J. V. Giorgi.
1992.
Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry.
Cytometry
13:204-208[CrossRef][Medline].
|
| 53.
|
Shapiro, H. M.
1989.
Flow cytometry of DNA content and other indicators of proliferative activity.
Arch. Pathol. Lab. Med.
113:591-597[Medline].
|
| 54.
|
Siegl, G.,
R. C. Bates,
K. I. Berns,
B. J. Carter,
D. C. Kelly,
E. Kurstak, and P. Tattersall.
1985.
Characteristics and taxonomy of Parvoviridae.
Intervirology
23:61-73[Medline].
|
| 55.
|
Smith, R. H., and R. M. Kotin.
2000.
An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA.
J. Virol.
74:3122-3129[Abstract/Free Full Text].
|
| 56.
|
Smith, R. H., and R. M. Kotin.
1998.
The Rep52 gene product of adeno-associated virus is a DNA helicase with 3'-to-5' polarity.
J. Virol.
72:4874-4881[Abstract/Free Full Text].
|
| 57.
|
Steller, H.
1995.
Mechanisms and genes of cellular suicide.
Science
267:1445-1449[Abstract/Free Full Text].
|
| 58.
|
Sunderman, F. W., Jr.
1995.
The influence of zinc on apoptosis.
Ann. Clin. Lab. Sci.
25:134-142[Abstract].
|
| 59.
|
Teodoro, J. G., and P. E. Branton.
1997.
Regulation of apoptosis by viral gene products.
J. Virol.
71:1739-1746[Medline].
|
| 60.
|
Vaux, D. L., and A. Strasser.
1996.
The molecular biology of apoptosis.
Proc. Natl. Acad. Sci. USA
93:2239-2244[Abstract/Free Full Text].
|
| 61.
|
Weger, S.,
M. Wendland,
J. A. Kleinschmidt, and R. Heilbronn.
1999.
The adeno-associated virus type 2 regulatory proteins Rep78 and Rep68 interact with the transcriptional coactivator PC4.
J. Virol.
73:260-269[Abstract/Free Full Text].
|
| 62.
|
Wonderling, R. S.,
S. R. M. Kyöstiö, and R. A. Owens.
1995.
A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities.
J. Virol.
69:3542-3548[Abstract].
|
| 63.
|
Wyllie, A. H.,
J. F. Kerr, and A. R. Currie.
1980.
Cell death: the significance of apoptosis.
Int. Rev. Cytol.
68:251-306[Medline].
|
| 64.
|
Yang, Q.,
F. Chen,
J. Ross, and J. P. Trempe.
1995.
Inhibition of cellular and SV40 DNA replication by the adeno-associated virus Rep proteins.
Virology
207:246-250[CrossRef][Medline].
|
| 65.
|
Yang, Q.,
F. Chen, and J. P. Trempe.
1994.
Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins.
J. Virol.
68:4847-4856[Abstract/Free Full Text].
|
| 66.
|
Zhou, C., and J. P. Trempe.
1999.
Induction of apoptosis by cadmium and the adeno-associated virus Rep proteins.
Virology
261:280-287[CrossRef][Medline].
|
| 67.
|
Zhou, C.,
Q. Yang, and J. P. Trempe.
1999.
Enhancement of UV-induced cytotoxicity by the adeno-associated virus replication proteins.
Biochim. Biophys. Acta
1444:371-383[Medline].
|
| 68.
|
Zhou, X.,
I. Zolotukhin,
D.-S. Im, and N. Muzyczka.
1999.
Biochemical characterization of adeno-associated virus Rep68 DNA helicase and ATPase activities.
J. Virol.
73:1580-1590[Abstract/Free Full Text].
|
Journal of Virology, October 2000, p. 9441-9450, Vol. 74, No. 20
0022-538X/00/$04.00+0
This article has been cited by other articles:
-
Daya, S., Berns, K. I.
(2008). Gene Therapy Using Adeno-Associated Virus Vectors. Clin. Microbiol. Rev.
21: 583-593
[Abstract]
[Full Text]
-
Arechavaleta-Velasco, F., Ma, Y., Zhang, J., McGrath, C. M., Parry, S.
(2006). Adeno-Associated Virus-2 (AAV-2) Causes Trophoblast Dysfunction, and Placental AAV-2 Infection Is Associated with Preeclampsia. Am. J. Pathol.
168: 1951-1959
[Abstract]
[Full Text]
-
Liu, Q., Perez, C. F., Wang, Y.
(2006). Efficient Site-Specific Integration of Large Transgenes by an Enhanced Herpes Simplex Virus/Adeno-Associated Virus Hybrid Amplicon Vector. J. Virol.
80: 1672-1679
[Abstract]
[Full Text]
-
Berthet, C., Raj, K., Saudan, P., Beard, P.
(2005). How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc. Natl. Acad. Sci. USA
102: 13634-13639
[Abstract]
[Full Text]
-
Schrenzel, M., Oaks, J. L., Rotstein, D., Maalouf, G., Snook, E., Sandfort, C., Rideout, B.
(2005). Characterization of a New Species of Adenovirus in Falcons. J. Clin. Microbiol.
43: 3402-3413
[Abstract]
[Full Text]
-
James, J. A., Aggarwal, A. K., Linden, R. M., Escalante, C. R.
(2004). Structure of adeno-associated virus type 2 Rep40-ADP complex: Insight into nucleotide recognition and catalysis by superfamily 3 helicases. Proc. Natl. Acad. Sci. USA
101: 12455-12460
[Abstract]
[Full Text]
-
Poole, B. D., Karetnyi, Y. V., Naides, S. J.
(2004). Parvovirus B19-Induced Apoptosis of Hepatocytes. J. Virol.
78: 7775-7783
[Abstract]
[Full Text]
-
Shen, Y.H., Utama, B., Wang, J., Raveendran, M., Senthil, D., Waldman, W.J., Belcher, J.D., Vercellotti, G., Martin, D., Mitchelle, B.M., Wang, X.L.
(2004). Human Cytomegalovirus Causes Endothelial Injury Through the Ataxia Telangiectasia Mutant and p53 DNA Damage Signaling Pathways. Circ. Res.
94: 1310-1317
[Abstract]
[Full Text]
-
Qiao, C., Wang, B., Zhu, X., Li, J., Xiao, X.
(2002). A Novel Gene Expression Control System and Its Use in Stable, High-Titer 293 Cell-Based Adeno-Associated Virus Packaging Cell Lines. J. Virol.
76: 13015-13027
[Abstract]
[Full Text]
-
Yang, G. S., Schmidt, M., Yan, Z., Lindbloom, J. D., Harding, T. C., Donahue, B. A., Engelhardt, J. F., Kotin, R., Davidson, B. L.
(2002). Virus-Mediated Transduction of Murine Retina with Adeno-Associated Virus: Effects of Viral Capsid and Genome Size. J. Virol.
76: 7651-7660
[Abstract]
[Full Text]
-
Moise, A. R., Grant, J. R., Vitalis, T. Z., Jefferies, W. A.
(2002). Adenovirus E3-6.7K Maintains Calcium Homeostasis and Prevents Apoptosis and Arachidonic Acid Release. J. Virol.
76: 1578-1587
[Abstract]
[Full Text]
-
Schmidt, M., Chiorini, J. A., Afione, S., Kotin, R.
(2002). Adeno-Associated Virus Type 2 Rep78 Inhibition of PKA and PRKX: Fine Mapping and Analysis of Mechanism. J. Virol.
76: 1033-1042
[Abstract]
[Full Text]
-
Cathomen, T., Stracker, T. H., Gilbert, L. B., Weitzman, M. D.
(2001). A genetic screen identifies a cellular regulator of adeno-associated virus. Proc. Natl. Acad. Sci. USA
10.1073/pnas.261567198v1
[Abstract]
[Full Text]
-
Ponnazhagan, S., Curiel, D. T., Shaw, D. R., Alvarez, R. D., Siegal, G. P.
(2001). Adeno-associated Virus for Cancer Gene Therapy. Cancer Res.
61: 6313-6321
[Full Text]
-
Cathomen, T., Stracker, T. H., Gilbert, L. B., Weitzman, M. D.
(2001). A genetic screen identifies a cellular regulator of adeno-associated virus. Proc. Natl. Acad. Sci. USA
98: 14991-14996
[Abstract]
[Full Text]